What is the duration of action of Losartan (angiotensin II receptor antagonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Action of Losartan

Losartan provides 24-hour blood pressure control with once-daily dosing, though its antihypertensive effect diminishes toward the end of the dosing interval, with 25-40% of peak inhibition persisting at 24 hours. 1

Pharmacokinetic Profile

The terminal half-life of losartan itself is approximately 2 hours, while its active metabolite (E-3174) has a half-life of 6-9 hours. 1 This active metabolite is responsible for most of the therapeutic effect and is 10-40 times more potent than the parent compound. 1, 2

  • Losartan reaches peak plasma concentrations in 1 hour after oral administration 1
  • The active metabolite E-3174 reaches peak concentrations in 3-4 hours 1
  • Only about 14% of an oral losartan dose is converted to the active metabolite, but the metabolite's area under the curve (AUC) is approximately 4 times greater than losartan itself 1

Duration of Antihypertensive Effect

A 100 mg dose of losartan inhibits the pressor effect of angiotensin II by approximately 85% at peak, with 25-40% inhibition persisting for 24 hours. 1 This pharmacodynamic profile supports once-daily dosing for most patients.

  • The antihypertensive effect is substantially present within one week, though maximal effect may take 3-6 weeks in some patients 1
  • In long-term studies, the effect of losartan was maintained for up to one year 1
  • There is no apparent rebound effect after abrupt withdrawal 1

Clinical Dosing Implications

For optimal 24-hour blood pressure control, the standard dose is 50-100 mg once daily, though some patients may benefit from twice-daily dosing at higher total daily doses. 3

  • The American College of Cardiology/American Heart Association guidelines list losartan's usual dose range as 50-100 mg/day with a daily frequency of "1 or 2" 3
  • For heart failure with reduced ejection fraction, the target dose is 100 mg once daily 4, 3
  • Higher doses (150 mg daily) may require twice-daily administration (75 mg twice daily) for more consistent 24-hour coverage 3

Trough-to-Peak Ratio

Studies using ambulatory blood pressure monitoring demonstrate that losartan maintains adequate antihypertensive effect throughout the 24-hour dosing interval. 5 A study with extended-release losartan formulation showed a trough-to-peak ratio of 0.91 for systolic blood pressure and 1.14 for diastolic blood pressure, with significant blood pressure reduction maintained during the last 4 hours before the next dose. 5

Common Pitfalls to Avoid

  • Do not assume losartan provides identical blood pressure control throughout the entire 24-hour period - the effect is strongest in the first 12 hours and diminishes toward the end of the dosing interval 1
  • Avoid underdosing - clinical trials support 100 mg daily as the target dose for optimal cardiovascular outcomes in heart failure, yet less than 25% of patients are titrated to target doses in clinical practice 3
  • Monitor blood pressure at trough (just before the next dose) to ensure adequate 24-hour control, as this is when the drug effect is weakest 5

References

Research

Clinical pharmacokinetics of losartan.

Clinical pharmacokinetics, 2005

Guideline

Optimal Dosing of Losartan for Hypertension and Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lisinopril to Losartan Conversion Equivalency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.